Completed PHASE2 INTERVENTIONAL 1-arm NCT01431313

Inhaled Nitrite in Subjects With Pulmonary Hypertension

A Dose Escalation Study to Evaluate the Effect of Inhaled Nitrite on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Hypertension

Sponsor: Schmidhofer, Mark, MD

Conditions Heart Failure, Diastolic Pulmonary Hypertension

Interventions Inhaled Nitrite

Updated 12 times since 2017 Last updated: Mar 15, 2019 Started: Jun 30, 2012 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Heart Failure, Diastolic and Pulmonary Hypertension, this trial is completed. The trial is conducted by Schmidhofer, Mark, MD and has accumulated 12 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Dec 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 7 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Apr 2019 — Jan 2021 [monthly]

Completed PHASE2
Aug 2018 — Apr 2019 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE2
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Feb 2017 — Oct 2017 [monthly]

Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Schmidhofer, Mark, MD

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States